Patient Cases - Plasma Cell Dyscrasia (PCD) - 6/26/2025

---

RSS

Thursday, June 26, 2025, 12:00 PM - 1:30 PM, Virtual


AMA PRA Category 1 Credits™ (1.50 hours), ANCC - Nursing Contact Hour(s) (1.50 hours), Non-Physician Attendance (1.50 hours)

This Plasma Cell Dyscrasia Tumor Board is a dynamic forum where different disciplines and professions come together to discuss challenging cases and develop personalized treatment plans for patients. This approach ensures patients receive the most up to date care based on their unique circumstances.

Objective(s): 1 Incorporate awareness among healthcare providers and implementing standardized screening protocols to identify cases. 2 Promote the use of advanced diagnostic techniques to improve accuracy and early detection of Plasma Cell Dyscrasia (PCD).
Location: Virtual
Specialties: Hematology

Faculty Disclosures:
Andres E Quesada, MD (Nothing to disclose - 11/20/2024)
Download Handout

1. Incorporate awareness among healthcare providers and implementing standardized screening protocols to identify cases.
2. Promote the use of advanced diagnostic techniques to improve accuracy and early detection of Plasma Cell Dyscrasia (PCD).

This series is closed. Please contact Gloria De Hoyos at [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.